The “North Tumor Clinical Trial” mini program is online! Yidu Technology (02158) helps open a new clinical trial service experience

The Zhitong Finance App learned how to make complex clinical trials more “friendly” to participants and more “efficient” for managers? At the touch of a finger, clinical trial visit schedules, reimbursement progress, and medication services can be controlled with just one click — this is no longer an idea. Recently, Yidu Technology (02158) and Peking University Cancer Hospital jointly created a clinical trial management system (CTMS) mobile terminal — the “North Tumor Clinical Trial” applet, officially launched. This not only puts the “patient-centered” concept into practice, but also marks a comprehensive upgrade in clinical trial management in terms of participant experience, data security, and execution efficiency.

Experience the three major upgrades: making clinical trial participation “worry-free and secure”

The newly launched CTMS applet is based on the test participants' experience to achieve a breakthrough upgrade from “management oriented” to “service oriented”. It is deeply integrated into the WeChat ecosystem, bringing many convenience to test participants in the mobile scenario:

Participation is more convenient. Test participants can check test news with one click through the WeChat Mini Program without having to download any app: the time, location, and inspection items are known in advance, the subsidy reimbursement progress can be checked in real time, and smart reminders can also be received. Furthermore, the mini program is seamlessly connected to Beizou's DTP (Direct Drug Delivery) system, allowing test participants to easily obtain drug services related to the test through the same portal, greatly reducing the participation threshold and providing a more intimate service experience.

Communicate more securely. Key communication is carried out through the company's WeChat official channel. Key medical data such as inspection reports and test plans are encrypted and transmitted through the CTMS platform. The data is safe and controllable, and the risk of unofficial channel circulation is avoided.

The experience is more coherent. Using the company's own WeChat function, when CRC personnel change, previous communication records and project information will be seamlessly handed over to avoid problems such as repeated communication between test participants and poor information connection, so that the test process is always consistent and smooth, and reduces the participation burden and communication costs of test participants.

This series of participant-centered improvements marks a successful expansion of the digitization of clinical trials from focusing on internal institutional process management to balancing the service experience of external participants.

The applet also greatly improves CRC's work efficiency. It breaks the limitations of office scenarios, and can synchronize PC tasks to the mobile phone to enable processing anytime and anywhere. At the same time, it supports core operations such as adding test participant information and modifying test participant status, reducing previous restrictions on fixed sites and equipment, and making work arrangements more flexible and efficient.

As the system continues to be iteratively upgraded, applications will also be expanded in more innovative scenarios such as remote electronic informed consent and rapid interpretation of mobile AE (adverse events) in the future.

Efficiency is visible: CTMS helps significantly reduce the average time to set up a project

Since Beimeng fully launched the Yidu Technology CTMS system in 2019, the two sides have continued to promote the evolution of the “Internet+ Clinical Trial Management” ecosystem.

The cooperation between the two sides covers many core scenarios from data governance to clinical research: the medical data intelligence platform built with the assistance of Yidu Technology provides a strong data insight foundation for scientific research and clinical research; the joint construction of multiple disease databases, represented by gastric cancer specialty banks, promoted standardized exploration of diagnosis and treatment standards; and the joint development and implementation of the MDT platform and research ward platform comprehensively enhanced the overall effectiveness of multidisciplinary collaboration and clinical research.

Based on this solid and extensive cooperation, the CTMS clinical research management system is a full-link digital intelligent management platform that meets GCP standards, providing a one-stop solution from project establishment, execution to completion of the project. Its value has been fully verified in practice: through systematic process standardization and detailed full-cycle control, the average project launch time for the Beihuang clinical trial project has been significantly reduced, and the efficiency is superior to the industry average.

The launch of the mobile terminal is based on this efficient management platform to further improve participant services and achieve dual improvements in management efficiency and patient experience.

Verified and marketable, the Yidu CTMS system has empowered 60+ hospitals across the country

The results of the collaboration with Beitou are an example of the value of Yidu Technology's CTMS system. As an important innovation released by Yidu Technology at the 2025 trade fair, the platform has been widely recognized for its reliability, professionalism and universality. It has now been successfully used in 60+ well-known hospitals across the country, supporting the efficient development of various complex clinical trials.

CTMS is not only a management tool for testing institutions, but also a key part of the entire R&D chain of “drug discovery - pre-clinical research - clinical trial - marketing approval” to help pharmaceutical research and development achieve intelligent transformation and improve the efficiency of the whole process.

In the future, Yidu Technology will continue to use its core technical advantages in the field of medical intelligence, promote high-quality technology and services to benefit more medical institutions, researchers and trial participants, effectively improve clinical research and development efficiency, and help safe and effective treatments benefit patients faster.